These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28164500)

  • 1. High BCL11A Expression in Adult Acute Myeloid Leukemia Patients Predicts a Worse Clinical Outcome.
    Dong H; Shi P; Zhou Y; Yu Y; Guo X; Yao Y; Liu P; Xu B
    Clin Lab; 2017 Jan; 63(1):85-90. PubMed ID: 28164500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL11A expression in acute myeloid leukemia.
    Tao H; Ma X; Su G; Yin J; Xie X; Hu C; Chen Z; Tan D; Xu Z; Zheng Y; Liu H; He C; Mao ZJ; Yin H; Wang Z; Chang W; Gale RP; Chen Z; Wu D; Yin B
    Leuk Res; 2016 Feb; 41():71-5. PubMed ID: 26707798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.
    Zhou JD; Yao DM; Han L; Xiao GF; Guo H; Zhang TJ; Li XX; Yuan Q; Yang L; Lin J; Qian J
    Tumour Biol; 2017 Apr; 39(4):1010428317699123. PubMed ID: 28443469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL11A and MDR1 expressions have prognostic impact in patients with acute myeloid leukemia treated with chemotherapy.
    Xutao G; PengCheng S; Yin L; Huijuan D; Yan W; Haiqing Z; Bing X
    Pharmacogenomics; 2018 Mar; 19(4):343-348. PubMed ID: 29469608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia.
    Zhou LY; Yin JY; Tang Q; Zhai LL; Zhang TJ; Wang YX; Yang DQ; Qian J; Lin J; Deng ZQ
    Int J Clin Exp Pathol; 2015; 8(12):16073-80. PubMed ID: 26884884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of miR-96 in patients with acute myeloid leukemia.
    Zhao J; Lu Q; Zhu J; Fu J; Chen YX
    Diagn Pathol; 2014 Mar; 9():76. PubMed ID: 24678958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
    Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
    Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL11A expression in acute phase chronic myeloid leukemia.
    Yin J; Zhang F; Tao H; Ma X; Su G; Xie X; Xu Z; Zheng Y; Liu H; He C; Mao ZJ; Wang Z; Chang W; Gale RP; Wu D; Yin B
    Leuk Res; 2016 Aug; 47():88-92. PubMed ID: 27285855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
    Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
    J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia.
    Zhang TJ; Wang YX; Yang DQ; Yao DM; Yang L; Zhou JD; Deng ZQ; Wen XM; Guo H; Ma JC; Lin J; Qian J
    Clin Lab; 2016; 62(1-2):113-20. PubMed ID: 27012040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.
    Kim HJ; Choi EJ; Sohn HJ; Park SH; Min WS; Kim TG
    Eur J Haematol; 2013 Nov; 91(5):411-22. PubMed ID: 23826993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
    Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
    J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.
    Willekens C; Blanchet O; Renneville A; Cornillet-Lefebvre P; Pautas C; Guieze R; Ifrah N; Dombret H; Jourdan E; Preudhomme C; Boissel N;
    Haematologica; 2016 Mar; 101(3):328-35. PubMed ID: 26635039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of OCT1 Expression in Acute Myeloid Leukemia.
    Stefanko E; Rybka J; Jaźwiec B; Haus O; Stąpor S; Kuliczkowski K; Wróbel T
    Pathol Oncol Res; 2017 Jul; 23(3):665-671. PubMed ID: 28025785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia.
    Xu L; Wu H; Wu X; Li Y; He D
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e124-e128. PubMed ID: 28544358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDH1 (E-cadherin) expression independently affects clinical outcome in acute myeloid leukemia with normal cytogenetics.
    Zhang TJ; Zhou JD; Ma JC; Deng ZQ; Qian Z; Yao DM; Yang J; Li XX; Lin J; Qian J
    Clin Chem Lab Med; 2017 Jan; 55(1):123-131. PubMed ID: 27305704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.